|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124.28 CHF | -0.02% |
|
-2.85% | +13.39% |
| 07-08 | Lancelot Sweden fell 0.8% in June, BioArctic slid despite Eli Lilly deal | FW |
| 07-07 | US FDA approves Vera's kidney disease drug | RE |
| Market Cap | 282B 247B 228B 210B 399B 26,901B 406B 2,719B 1,068B 13,252B 1,059B 1,036B 45,558B | P/E 2026 * |
21.5x | P/E 2027 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 314B 275B 253B 234B 444B 29,955B 452B 3,028B 1,189B 14,757B 1,179B 1,154B 50,731B | EV / Sales 2026 * |
5.52x | EV / Sales 2027 * | 5.15x |
| Free-Float |
91.66% | Yield 2026 * |
2.86% | Yield 2027 * | 2.95% |
Last Transcript: Novartis AG
| 1 day | -0.07% | ||
| 1 week | -2.85% | ||
| Current month | -1.82% | ||
| 1 month | +4.40% | ||
| 3 months | +2.07% | ||
| 6 months | +9.17% | ||
| Current year | +13.39% |
| 1 week | 124.1 |  | 128.7 |
| 1 month | 117.96 | | 128.92 |
| Current year | 107.68 | | 131 |
| 1 year | 91.2 | | 131 |
| 3 years | 81.1 | | 131 |
| 5 years | 72.84 | | 131 |
| 10 years | 65.09 | | 131 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 01/02/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 16/03/2026 |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 64 | 16/05/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 01/01/2015 |
| Director/Board Member | 69 | 01/01/2016 | |
Ton Büchner
BRD | Director/Board Member | 61 | 01/01/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-18 | Sell | -5,200 | 0.0003% | |||
| 05-04 | Sell | 6,800 | 0.0003% | |||
| 02-17 | Sell | 30,743 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.02% | -2.85% | +25.27% | +44.88% | 282B | |
| -2.42% | -1.33% | +49.77% | +161.31% | 1,085B | |
| -0.98% | -1.16% | +62.55% | +60.69% | 624B | |
| -1.34% | -3.37% | +26.25% | +83.05% | 442B | |
| +0.33% | -1.17% | +27.98% | +26.90% | 332B | |
| -3.89% | -11.22% | +20.78% | +26.07% | 277B | |
| +0.66% | -1.42% | -29.26% | -39.30% | 217B | |
| -0.53% | -1.36% | +20.34% | +60.85% | 196B | |
| -3.79% | +0.22% | +13.41% | +71.62% | 167B | |
| +0.10% | +2.28% | -5.90% | -32.01% | 138B | |
| Average | -1.25% | -1.71% | +21.12% | +46.41% | 376.01B | |
| Weighted average by Cap. | -1.50% | -1.03% | +33.47% | +76.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 56.86B 49.74B 45.88B 42.37B 80.4B 5,423B 81.75B 548B 215B 2,672B 214B 209B 9,185B | 60.3B 52.74B 48.65B 44.93B 85.26B 5,751B 86.69B 581B 228B 2,833B 226B 221B 9,740B |
| Net income | 14.08B 12.31B 11.36B 10.49B 19.91B 1,343B 20.24B 136B 53.3B 661B 52.86B 51.71B 2,274B | 15.64B 13.68B 12.62B 11.66B 22.12B 1,492B 22.49B 151B 59.22B 735B 58.73B 57.46B 2,527B |
| Net Debt | 32.03B 28.01B 25.84B 23.86B 45.28B 3,054B 46.04B 309B 121B 1,505B 120B 118B 5,173B | 28.54B 24.96B 23.02B 21.26B 40.35B 2,722B 41.03B 275B 108B 1,341B 107B 105B 4,609B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | CHF 124.28 | -0.02% | 2,334,841 |
| 09/07/26 | CHF 124.30 | -1.27% | 2,233,204 |
| 08/07/26 | CHF 125.90 | -0.71% | 2,243,169 |
| 07/07/26 | CHF 126.80 | +1.36% | 2,306,045 |
| 06/07/26 | CHF 125.10 | -2.20% | 2,283,429 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
